XTL Biopharmaceuticals Ltd (XTLB) — Tangible Net Worth Ratio
XTL Biopharmaceuticals Ltd (XTLB) has a Tangible Net Worth Ratio of 29.8% as of December 2024. This metric is calculated by deducting intangible assets (ILA3.82 Million) from net assets (ILA5.43 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See working capital to net assets of XTL Biopharmaceuticals Ltd to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
XTL Biopharmaceuticals Ltd Tangible Net Worth Ratio (2013–2024)
This chart shows how XTL Biopharmaceuticals Ltd's Tangible Net Worth Ratio has changed across 12 annual periods from 2013 to 2024. As of December 2024, the ratio stands at 29.8%, reflecting net assets of ILA5.43 Million with intangible assets of ILA3.82 Million ILA. See defensive interval ratio of XTL Biopharmaceuticals Ltd to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd (2013–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for XTL Biopharmaceuticals Ltd from 2013 to 2024, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see XTLB market cap.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 29.8% | ILA5.43 Million | ILA3.82 Million | ILA8.55 Million | ▼ -53.1 pp |
| 2023 | 82.9% | ILA2.22 Million | ILA380.00K | ILA2.43 Million | ▼ -7.6 pp |
| 2022 | 90.5% | ILA4.00 Million | ILA380.00K | ILA4.19 Million | ▼ -2.4 pp |
| 2021 | 92.9% | ILA5.33 Million | ILA380.00K | ILA6.62 Million | ▼ -1.0 pp |
| 2020 | 93.9% | ILA6.25 Million | ILA380.00K | ILA6.50 Million | ▼ -0.6 pp |
| 2019 | 94.6% | ILA6.98 Million | ILA380.00K | ILA7.21 Million | ▼ -0.9 pp |
| 2018 | 95.4% | ILA8.32 Million | ILA380.00K | ILA8.57 Million | ▲ +5.9 pp |
| 2017 | 89.5% | ILA3.62 Million | ILA380.00K | ILA6.59 Million | ▼ -1.1 pp |
| 2016 | 90.6% | ILA2.69 Million | ILA253.00K | ILA3.02 Million | ▲ +11.8 pp |
| 2015 | 78.8% | ILA4.89 Million | ILA1.04 Million | ILA5.32 Million | ▲ +32.2 pp |
| 2014 | 46.6% | ILA4.68 Million | ILA2.50 Million | ILA5.64 Million | ▼ -11.2 pp |
| 2013 | 57.8% | ILA6.79 Million | ILA2.87 Million | ILA8.02 Million | — |